 LEIDEN, Netherlands CAMBRIDGE, Mass., April 04, 2022 GLOBE NEWSWIRE -- ProQR Therapeutics N.V. Nasdaq: PRQR the Company, a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced a presentation at the 3rd RNA Editing Summit held April 5-7 in Boston, MA, US. 